Clinical Trials in Los Angeles

Showing 6981-7000 of 12,794 trials

Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

NCT03883360

A large proportion of people with a schizophrenia-spectrum disorder, especially in the early stages of the disease, regularly consume cannabis. Cannabis use is associated with poor prognostic outcome; however, there are no effective interventions targeted at reducing cannabis use or its deleterious effects in this population. The present trial is designed to test whether cannabidiol (CBD), a cannabinoid whose effects are in many ways antagonistic to those of Δ9-tetrahydrocannabinol (THC), can reduce psychiatric symptoms, cognitive deficits, and cannabis use in people with recent-onset psychosis who regularly consume cannabis.

Schizophrenia Spectrum DisordersCannabis Use

University of Maryland, BaltimoreStarted Jan 2050

Los Angeles, California, United States • Baltimore, Maryland, United States • Catonsville, Maryland, United States

TERMINATEDPhase 3< 1 mile

UNITE Study: Understanding New Interventions With GBM ThErapy

NCT03419403

The objective of this study was to evaluate the effect of several ophthalmologic prophylactic treatment strategies for the management of ocular side effects (OSEs) in participants with epidermal growth factor receptor (EGFR)-amplified glioblastoma (GBM) who were being treated with depatuxizumab mafodotin (ABT-414).

Glioblastoma Multiforme

AbbVie40 participantsStarted Jul 2018

Los Angeles, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +19 more locations

Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

UNITE Study: Understanding New Interventions With GBM ThErapy

Find Trials by Condition in Los Angeles

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

A Phase II Study of M2951 in SLE

Study of CAD-1883 for Spinocerebellar Ataxia

Rheos System for the Treatment of HFpEF Heart Failure

Prunes for Gastrointestinal Function After Gynecologic Surgery

Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain

A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

Robotics For Rehabilitation Therapy: Functional Versus Individual Joint Training

Improving Dental Care and Oral Health in Children With Autism Spectrum Disorder

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS